768 related articles for article (PubMed ID: 28637492)
21. Deciphering transcription dysregulation in FSH muscular dystrophy.
Ehrlich M; Lacey M
J Hum Genet; 2012 Aug; 57(8):477-84. PubMed ID: 22718021
[TBL] [Abstract][Full Text] [Related]
22. Integrated functions of Pax3 and Pax7 in the regulation of proliferation, cell size and myogenic differentiation.
Collins CA; Gnocchi VF; White RB; Boldrin L; Perez-Ruiz A; Relaix F; Morgan JE; Zammit PS
PLoS One; 2009; 4(2):e4475. PubMed ID: 19221588
[TBL] [Abstract][Full Text] [Related]
23. Biphasic myopathic phenotype of mouse DUX, an ORF within conserved FSHD-related repeats.
Bosnakovski D; Daughters RS; Xu Z; Slack JM; Kyba M
PLoS One; 2009 Sep; 4(9):e7003. PubMed ID: 19756142
[TBL] [Abstract][Full Text] [Related]
24. Ret function in muscle stem cells points to tyrosine kinase inhibitor therapy for facioscapulohumeral muscular dystrophy.
Moyle LA; Blanc E; Jaka O; Prueller J; Banerji CR; Tedesco FS; Harridge SD; Knight RD; Zammit PS
Elife; 2016 Nov; 5():. PubMed ID: 27841748
[TBL] [Abstract][Full Text] [Related]
25. A complex interplay of genetic and epigenetic events leads to abnormal expression of the DUX4 gene in facioscapulohumeral muscular dystrophy.
Gatica LV; Rosa AL
Neuromuscul Disord; 2016 Dec; 26(12):844-852. PubMed ID: 27816329
[TBL] [Abstract][Full Text] [Related]
26. Facioscapulohumeral dystrophy transcriptome signatures correlate with different stages of disease and are marked by different MRI biomarkers.
van den Heuvel A; Lassche S; Mul K; Greco A; San León Granado D; Heerschap A; Küsters B; Tapscott SJ; Voermans NC; van Engelen BGM; van der Maarel SM
Sci Rep; 2022 Jan; 12(1):1426. PubMed ID: 35082321
[TBL] [Abstract][Full Text] [Related]
27. Zac1/GPR39 phosphorylating CaMK-II contributes to the distinct roles of Pax3 and Pax7 in myogenic progression.
Yang Q; Li Y; Zhang X; Chen D
Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):407-419. PubMed ID: 29079520
[TBL] [Abstract][Full Text] [Related]
28. Facioscapulohumeral muscular dystrophy family studies of DUX4 expression: evidence for disease modifiers and a quantitative model of pathogenesis.
Jones TI; Chen JC; Rahimov F; Homma S; Arashiro P; Beermann ML; King OD; Miller JB; Kunkel LM; Emerson CP; Wagner KR; Jones PL
Hum Mol Genet; 2012 Oct; 21(20):4419-30. PubMed ID: 22798623
[TBL] [Abstract][Full Text] [Related]
29. The DUX4-HIF1α Axis in Murine and Human Muscle Cells: A Link More Complex Than Expected.
Nguyen TH; Limpens M; Bouhmidi S; Paprzycki L; Legrand A; Declèves AE; Heher P; Belayew A; Banerji CRS; Zammit PS; Tassin A
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542301
[TBL] [Abstract][Full Text] [Related]
30. DUX4 induces a transcriptome more characteristic of a less-differentiated cell state and inhibits myogenesis.
Knopp P; Krom YD; Banerji CR; Panamarova M; Moyle LA; den Hamer B; van der Maarel SM; Zammit PS
J Cell Sci; 2016 Oct; 129(20):3816-3831. PubMed ID: 27744317
[TBL] [Abstract][Full Text] [Related]
31. Influence of
Duranti E; Villa C
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298453
[TBL] [Abstract][Full Text] [Related]
32. PAX7 target gene repression associates with FSHD progression and pathology over 1 year.
Banerji CRS
Hum Mol Genet; 2020 Aug; 29(13):2124-2133. PubMed ID: 32347924
[TBL] [Abstract][Full Text] [Related]
33. Remodeling of the chromatin structure of the facioscapulohumeral muscular dystrophy (FSHD) locus and upregulation of FSHD-related gene 1 (FRG1) expression during human myogenic differentiation.
Bodega B; Ramirez GD; Grasser F; Cheli S; Brunelli S; Mora M; Meneveri R; Marozzi A; Mueller S; Battaglioli E; Ginelli E
BMC Biol; 2009 Jul; 7():41. PubMed ID: 19607661
[TBL] [Abstract][Full Text] [Related]
34. Hypoxia enhances human myoblast differentiation: involvement of HIF1α and impact of DUX4, the FSHD causal gene.
Nguyen TH; Paprzycki L; Legrand A; Declèves AE; Heher P; Limpens M; Belayew A; Banerji CRS; Zammit PS; Tassin A
Skelet Muscle; 2023 Dec; 13(1):21. PubMed ID: 38104132
[TBL] [Abstract][Full Text] [Related]
35. A patient-derived iPSC model revealed oxidative stress increases facioscapulohumeral muscular dystrophy-causative DUX4.
Sasaki-Honda M; Jonouchi T; Arai M; Hotta A; Mitsuhashi S; Nishino I; Matsuda R; Sakurai H
Hum Mol Genet; 2018 Dec; 27(23):4024-4035. PubMed ID: 30107443
[TBL] [Abstract][Full Text] [Related]
36. Generation of isogenic D4Z4 contracted and noncontracted immortal muscle cell clones from a mosaic patient: a cellular model for FSHD.
Krom YD; Dumonceaux J; Mamchaoui K; den Hamer B; Mariot V; Negroni E; Geng LN; Martin N; Tawil R; Tapscott SJ; van Engelen BG; Mouly V; Butler-Browne GS; van der Maarel SM
Am J Pathol; 2012 Oct; 181(4):1387-401. PubMed ID: 22871573
[TBL] [Abstract][Full Text] [Related]
37. Membrane Repair Deficit in Facioscapulohumeral Muscular Dystrophy.
Bittel AJ; Sreetama SC; Bittel DC; Horn A; Novak JS; Yokota T; Zhang A; Maruyama R; Rowel Q Lim K; Jaiswal JK; Chen YW
Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32759720
[TBL] [Abstract][Full Text] [Related]
38. Asymmetric bidirectional transcription from the FSHD-causing D4Z4 array modulates DUX4 production.
Block GJ; Petek LM; Narayanan D; Amell AM; Moore JM; Rabaia NA; Tyler A; van der Maarel SM; Tawil R; Filippova GN; Miller DG
PLoS One; 2012; 7(4):e35532. PubMed ID: 22536400
[TBL] [Abstract][Full Text] [Related]
39. The FSHD atrophic myotube phenotype is caused by DUX4 expression.
Vanderplanck C; Ansseau E; Charron S; Stricwant N; Tassin A; Laoudj-Chenivesse D; Wilton SD; Coppée F; Belayew A
PLoS One; 2011; 6(10):e26820. PubMed ID: 22053214
[TBL] [Abstract][Full Text] [Related]
40. Direct interplay between two candidate genes in FSHD muscular dystrophy.
Ferri G; Huichalaf CH; Caccia R; Gabellini D
Hum Mol Genet; 2015 Mar; 24(5):1256-66. PubMed ID: 25326393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
